EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Treatment of patients with pMMR GI cancers with tumor-infiltrating lymphocytes (TIL): a reality?

John B Haanen

Trends in Cancer · 2025

DOI: 10.1016/j.trecan.2025.05.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trends in Cancer, 2025. Verfasst von John B Haanen. Beteiligte Einrichtung: Division of Medical Oncology, NKI, Amsterdam, Netherlands; Department of Medical Oncology, LUMC, Leiden, Netherlands; Oncology Service, CHUV, Lausann…. Hauptthemen laut MEDLINE: Lymphocytes, Tumor-Infiltrating, Gastrointestinal Neoplasms, Immunotherapy, Adoptive. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A recent study published in Nature Medicine shows that adoptive cell therapy using neoantigen-selected tumor-infiltrating lymphocytes (TIL) is feasible in refractory metastatic gastrointestinal (GI) cancers, showing durable responses, especially when combined with anti-PD-1. Despite low tumor mutational burden (TMB), enriched neoantigen-reactive TIL improved objective response rates (ORR), highlighting the role of the tumor microenvironment and supporting further clinical development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphocytes, Tumor-InfiltratingGastrointestinal NeoplasmsImmunotherapy, AdoptiveHumansTumor MicroenvironmentImmune Checkpoint InhibitorsAntigens, NeoplasmTreatment OutcomeDrug Resistance, NeoplasmMutationProgrammed Cell Death 1 Receptor

Substanzen

Immune Checkpoint InhibitorsAntigens, NeoplasmProgrammed Cell Death 1 Receptor

Autor:innen und Institutionen

  • Division of Medical Oncology, NKI, Amsterdam, Netherlands; Department of Medical Oncology, LUMC, Leiden, Netherlands; Oncology Service, CHUV, Lausanne, Switzerland. Electronic address: j.haanen@nki.nl.

Zitieren

APA

Haanen, J. B. (2025). Treatment of patients with pMMR GI cancers with tumor-infiltrating lymphocytes (TIL): a reality?. Trends in Cancer. https://doi.org/10.1016/j.trecan.2025.05.004

Vancouver

Haanen JB. Treatment of patients with pMMR GI cancers with tumor-infiltrating lymphocytes (TIL): a reality?. Trends in Cancer. 2025. doi:10.1016/j.trecan.2025.05.004

BibTeX
@article{Haanen2025,
  author = {Haanen, John B},
  title = {Treatment of patients with pMMR GI cancers with tumor-infiltrating lymphocytes (TIL): a reality?},
  journal = {Trends in Cancer},
  year = {2025},
  doi = {10.1016/j.trecan.2025.05.004}
}
Kostenlos starten →